Inactive Instrument

Press Releases Novadel Pharma Inc

Equities

NVDL

US66986X1063

End-of-day quote OTC Bulletin Board Other stock markets
- ^USD	-

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

NovaDel Pharma Inc. : Announces Dissolution of the Company	22/02/17	BU
Novadel Pharma : Reports Resolution of Contingent Liabilities	04/02/16	BU
Novadel Pharma : Announces Update to Agreement with Amherst Pharmaceuticals	30/01/15	BU
Novadel Pharma : Announces the Sale of Its ZolpiMist® New Drug Application, License and Intellectual Property to Amherst Pharmaceuticals, LLC	22/09/14	BU
Novadel Pharma : Announces Proposed Actions to Complete Liquidation of Assets and Cash Distribution to Shareholders	26/03/14	BU
Novadel Pharma Inc : NovaDel Announces the Sale of its NitroMist® New Drug Application, License and Intellectual Property to Mist Pharmaceuticals, LLC.	19/11/13	BU
Novadel Pharma Inc : NovaDel Announces Completion of the Sale of Substantially All Assets to Suda Ltd.	13/08/13	BU
Novadel Pharma Inc : NovaDel Announces Stockholder Approval of Sale of Substantially All Assets to Suda Ltd.	19/07/13	BU
Novadel Pharma Inc : NovaDel Announces Adjournment of Special Stockholder Meeting	27/06/13	BU
Novadel Pharma Inc : NovaDel Announces the Signing of a Definitive Agreement to Sell its NovaMist? Technology and Certain Other Assets	08/04/13	BU
Novadel Pharma Inc : NovaDel Reports Unaudited Financial Results for the Twelve Months Ended December 31, 2012	27/03/13	BU
Novadel Pharma Inc : NovaDel Announces Preliminary Agreement to Sell its NovaMist(tm) Technology	26/12/12	PU
Novadel Pharma Inc : NovaDel Announces Preliminary Agreement to Sell its NovaMist? Technology	26/12/12	BU
Novadel Pharma Inc : NovaDel Reports Unaudited Financial Results for the Nine Months Ended September 30, 2012	15/11/12	BU
Novadel Pharma Inc : NovaDel Reports Unaudited Financial Results for the Six Months Ended June 30, 2012	31/07/12	BU
Novadel Pharma Inc : NovaDel Reports Unaudited Financial Results for Fourth Quarter and Year Ended December 31, 2011	20/03/12	BU
Novadel Pharma Inc : NovaDel Announces Termination of License Agreements for Ondansetron Oral Spray Product	20/01/12	BU
Novadel Pharma Inc : NovaDel Continuing to Explore Strategic Alternatives	18/01/12	BU
Novadel Pharma Inc : NovaDel Reports Financial Results for Third Quarter 2011	01/11/11	BU
NOVADEL PHAMA : NovaDel Pharma Inc. Recent Events	30/08/11	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Novadel Pharma Inc

Equities

NVDL

US66986X1063

Press Releases

Filters